DE

Decollte Holdings Corporation

A nationwide network of studios offering modern wedding photography and wellness services.

7372 | T

Overview

Corporate Details

ISIN(s):
JP3548830003
LEI:
Country:
Japan
Address:
神戸市中央区加納町4丁目4番17号 ニッセイ三宮ビル12階
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

Decollte Holdings Corporation is a leading company in the photo wedding industry. It operates a nationwide network of photography studios under brands such as Studio AQUA, TVB, and Eito. The company specializes in wedding and anniversary photo services, emphasizing a natural, modern aesthetic and studio designs that cater to contemporary needs. Beyond its core photography business, Decollte Holdings also provides services in the wellness sector, including fitness programs. The company's overarching mission is to deliver 'Happiness, Beauty, and Wellness' by supporting the physical and mental well-being of its customers through its diverse service platforms.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-05-08 09:48
Report Publication Announcement
確認書
Japanese 8.2 KB
2025-05-08 09:00
Interim Report
半期報告書-第9期(2024/10/01-2025/09/30)
Japanese 212.8 KB
2025-04-25 09:00
Related Party Transaction
臨時報告書
Japanese 28.4 KB
2025-04-10 08:31
Major Shareholding Notification
臨時報告書
Japanese 20.8 KB
2024-12-20 08:24
Regulatory News Service
臨時報告書
Japanese 22.7 KB
2024-12-20 08:03
Regulatory News Service
内部統制報告書-第8期(2023/10/01-2024/09/30)
Japanese 21.8 KB
2024-12-20 08:02
Registration Form
確認書
Japanese 8.2 KB
2024-12-20 08:00
Annual Report
有価証券報告書-第8期(2023/10/01-2024/09/30)
Japanese 1015.9 KB
2024-05-07 09:02
Report Publication Announcement
確認書
Japanese 8.2 KB
2024-05-07 09:01
Quarterly Report
四半期報告書-第8期第2四半期(2024/01/01-2024/03/31)
Japanese 223.9 KB
2024-02-05 08:01
Regulatory News Service
確認書
Japanese 8.2 KB
2024-02-05 08:00
Quarterly Report
四半期報告書-第8期第1四半期(2023/10/01-2023/12/31)
Japanese 195.2 KB
2023-12-22 08:41
Post-Annual General Meeting Information
臨時報告書
Japanese 23.8 KB
2023-12-22 08:33
Registration Form
確認書
Japanese 8.2 KB
2023-12-22 08:30
Governance Information
内部統制報告書-第7期(2022/10/01-2023/09/30)
Japanese 21.8 KB

Automate Your Workflow. Get a real-time feed of all Decollte Holdings Corporation filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Decollte Holdings Corporation

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Decollte Holdings Corporation via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

1NKEMIA Logo
A tech group providing R&D, services, training, and investment for life sciences industries.
Spain
IKM
AI-powered genome sequencing and reanalysis to diagnose rare diseases globally.
South Korea
394800
4D Molecular Therapeutics, Inc. Logo
Developing targeted AAV genetic medicines for large market eye, lung, and heart diseases.
United States of America
FDMT
AbCellera Biologics Inc. Logo
An AI-powered platform that discovers and develops antibody therapeutics for pharma partners.
United States of America
ABCL
Develops antibody therapeutics and CAR-T for oncology and provides CRO services.
South Korea
174900
Clinical-stage biopharma developing therapeutics for oncology & viral infectious diseases.
South Korea
203400
Abivax S.A. Logo
Biotech developing oral drugs for chronic inflammatory diseases like colitis and Crohn's.
United States of America
ABVX
ABL Bio Inc. Logo
Develops bispecific antibody therapies for oncology and neurodegenerative diseases.
South Korea
298380
Absci Corp Logo
A generative AI drug creation platform for designing and optimizing biologic therapeutics.
United States of America
ABSI
ABVC BIOPHARMA, INC. Logo
Develops plant-based drugs and medical devices for CNS, oncology, and ophthalmic disorders.
United States of America
ABVC

Talk to a Data Expert

Have a question? We'll get back to you promptly.